Co-Founding VoyagerMed: Selling Trust in Healthcare

Co-Founding VoyagerMed: What Healthcare Taught Me About Selling Trust

In 2012, I co-founded VoyagerMed with a premise that sounds simple in retrospect but proved extraordinarily difficult to execute: connect patients facing serious, often life-altering diagnoses with leading U.S. physicians who could provide second opinions, specialized consultations, and access to care that simply wasn't available in their local markets. It was a genuinely important mission. It was also the hardest sales environment I have ever operated in — and I've sold enterprise SaaS into Fortune 500 boardrooms, structured complex financial instruments on Wall Street, and pitched AI platforms to institutional hedge funds.

Nothing compares to selling in a moment of real human vulnerability.

The Market Nobody Wanted to Touch

Healthcare technology was — and still largely is — a sector defined by institutional inertia, fragmented decision-making, and a deeply justified skepticism toward outside technology vendors. Hospitals and health systems had been burned by overpromised EHR implementations. Physicians were drowning in administrative burden from poorly designed software. And patients, particularly those navigating serious illness, had zero patience for friction, jargon, or anything that felt remotely transactional.

Coming in as a technology company — even a well-intentioned one — meant starting every conversation with a credibility deficit. The burden of proof was entirely on us.

That reality fundamentally shaped how I built the commercial function at VoyagerMed as CRO. I recognized early that we weren't selling software features. We weren't even selling access to physicians, exactly. We were selling the belief that someone genuinely had the patient's best interest at heart — that there was a trustworthy process on the other end of a very difficult phone call or web inquiry. In a market flooded with noise and fear, trust was the only currency that actually spent.

Rethinking What a Sales Team Actually Does

Most sales organizations are built around pipeline mechanics: lead volume, conversion rates, average contract value, cycle length. Those metrics matter — I tracked all of them. But if you optimize exclusively for pipeline velocity in a high-stakes healthcare context, you will destroy the very thing that makes your business work. You will push too hard, listen too little, and lose the patient — not just the deal.

I built VoyagerMed's sales team around a different first principle: empathy before product, every time.

That meant hiring differently. I wasn't looking for the most aggressive closers. I was looking for people who could hold space in a hard conversation — who could listen to a patient describe a cancer diagnosis or a child's rare condition and respond with genuine human presence before ever mentioning what VoyagerMed offered. Emotional intelligence wasn't a soft skill on the periphery. It was the core competency.

It also meant coaching differently. My job as a sales leader wasn't just to review call recordings for objection handling. It was to mentor reps on the weight of what they were doing — on the responsibility of being a trusted voice to someone who was frightened and overwhelmed. I wanted reps who understood that a single bad interaction didn't just lose a customer. It potentially sent a sick person away without the help they needed.

"The standard pitch-and-close motion doesn't just fail in healthcare. It causes harm. And the best salespeople I've ever worked with understood that intuitively."

What Trust Actually Looks Like at Scale

Building a trust-first sales culture sounds straightforward as a philosophy. The operational complexity is in making it consistent, measurable, and scalable. Here's what that looked like in practice at VoyagerMed:

• Discovery before prescription. Reps were trained to spend the first significant portion of every conversation purely in listening mode — understanding the patient's specific situation, what they'd already been told, and what they were actually afraid of. Only then did we begin to map our offering to their need.
• Honest scoping. If VoyagerMed wasn't the right fit for a given patient's situation, we said so. This counterintuitive practice — turning away potential revenue — built more referral trust with physicians and patient advocacy networks than any marketing campaign ever could.
• Institutional credibility as infrastructure. We invested heavily in the physician relationships and clinical protocols that allowed us to say, with complete confidence, that the specialists on our platform were legitimately elite. Trust isn't a messaging strategy. It requires the underlying substance to back it up.
• Follow-through as differentiation. In healthcare, the experience after the sale matters enormously. A patient who got seamless, compassionate coordination through their consultation became an advocate. A patient who encountered friction became a liability. We treated post-sale experience as a core sales function, not an afterthought.

The Lesson That Has Never Left Me

Every business I've built or led since VoyagerMed has operated in some version of a high-stakes environment — where the buyer carries real weight into the conversation, where the cost of a broken promise isn't just churn but genuine damage. Wall Street clients. Healthcare systems. Enterprise SaaS buyers with seven-figure decisions on the line. Institutional investors evaluating AI platforms at HedgeNova today.

In every one of those contexts, the fundamental dynamic is the same. The sophistication of the buyer scales up. The vulnerability is more professional than personal. But the underlying question they're asking hasn't changed: Can I trust you?

VoyagerMed taught me that trust is not a feature you demonstrate in a demo. It is not a talking point in a deck. It is the accumulated result of how you listen, how you scope honestly, how you follow through on commitments, and how you behave when the deal is under pressure. It is extraordinarily difficult to build and trivially easy to destroy.

Why Healthcare Is Still the Hardest Market — and the Most Instructive

I have deep respect for the founders trying to move healthcare forward with technology. The sector is frustratingly slow, highly regulated, and resistant to change — often for legitimate reasons rooted in patient safety. But those constraints are exactly what make it such a valuable proving ground for any commercial leader.

If you can build a scalable, trust-based sales motion in an environment where the stakes are this high and the skepticism this deep, you can sell anything. Not because the tactics transfer directly, but because the mindset does. You learn to slow down when the instinct is to push. You learn that credibility compounds and shortcuts compound against you. You learn that the best close is a patient who never felt closed at all — just genuinely helped.

That is the lesson I carried out of VoyagerMed. It is embedded in how I build teams, structure commercial strategy, and think about customer relationships at every stage of the businesses I lead today. In a world where AI is making it cheaper and faster to reach more buyers than ever before, the executives who understand how to earn trust — not just generate pipeline — will be the ones who build something that lasts.